These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 12892875)

  • 1. Dopamine receptor hetero-oligomerization in the pathogenesis of schizophrenia: qualitative as opposed to quantitative notions of dopaminergic receptors.
    Tsai SJ; Hong CJ
    Schizophr Res; 2003 Sep; 63(1-2):197-8. PubMed ID: 12892875
    [No Abstract]   [Full Text] [Related]  

  • 2. Dopamine receptor signaling molecules are altered in elderly schizophrenic cortex.
    Baracskay KL; Haroutunian V; Meador-Woodruff JH
    Synapse; 2006 Sep; 60(4):271-9. PubMed ID: 16786528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Signal transmission, rather than reception, is the underlying neurochemical abnormality in schizophrenia.
    Dean B
    Aust N Z J Psychiatry; 2000 Aug; 34(4):560-9. PubMed ID: 10954386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Striatal D2 dopaminergic receptors assessed with positron emission tomography and [76Br]bromospiperone in untreated schizophrenic patients.
    Martinot JL; Peron-Magnan P; Huret JD; Mazoyer B; Baron JC; Boulenger JP; Loc'h C; Maziere B; Caillard V; Loo H
    Am J Psychiatry; 1990 Jan; 147(1):44-50. PubMed ID: 2293788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Down-regulation of central dopamine receptors in schizophrenia.
    Zemlan FP; Hitzemann RJ; Hirschowitz J; Garver DL
    Am J Psychiatry; 1985 Nov; 142(11):1334-7. PubMed ID: 2865903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for reduced and dysregulated turnover of dopamine in schizophrenia.
    Heritch AJ
    Schizophr Bull; 1990; 16(4):605-15. PubMed ID: 2077638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is there a right hemi-hyper-dopaminergic psychosis?
    Bracha HS
    Schizophr Res; 1989; 2(4-5):317-24. PubMed ID: 2487172
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Schizophrenia: D4 receptor elevation. What does it mean?
    Seeman MV
    J Psychiatry Neurosci; 1994 May; 19(3):171-6. PubMed ID: 7913338
    [No Abstract]   [Full Text] [Related]  

  • 9. Dopamine, the prefrontal cortex and schizophrenia.
    Knable MB; Weinberger DR
    J Psychopharmacol; 1997; 11(2):123-31. PubMed ID: 9208376
    [TBL] [Abstract][Full Text] [Related]  

  • 10. D1 and D2 and D3.
    Healy D
    Br J Psychiatry; 1991 Sep; 159():319-24. PubMed ID: 1683592
    [No Abstract]   [Full Text] [Related]  

  • 11. Schizophrenia and dopamine receptors.
    Seeman P
    Eur Neuropsychopharmacol; 2013 Sep; 23(9):999-1009. PubMed ID: 23860356
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopaminergic abnormalities in select thalamic nuclei in schizophrenia: involvement of the intracellular signal integrating proteins calcyon and spinophilin.
    Clinton SM; Ibrahim HM; Frey KA; Davis KL; Haroutunian V; Meador-Woodruff JH
    Am J Psychiatry; 2005 Oct; 162(10):1859-71. PubMed ID: 16199832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psychopathological correlates of reduced dopamine receptor sensitivity in depression, schizophrenia, and opiate and alcohol dependence.
    Schmidt K; Nolte-Zenker B; Patzer J; Bauer M; Schmidt LG; Heinz A
    Pharmacopsychiatry; 2001 Mar; 34(2):66-72. PubMed ID: 11302566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Psychopharmacologic approaches to schizophrenic psychoses].
    Giacardy-Paty M; Soubrouillard C; Blin O
    Encephale; 1995 Jun; 21 Spec No 3():3-8. PubMed ID: 7628339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brain dopamine receptors in schizophrenia: PET problems.
    Seeman P
    Arch Gen Psychiatry; 1988 Jun; 45(6):598-600. PubMed ID: 3259865
    [No Abstract]   [Full Text] [Related]  

  • 16. Dopamine in schizophrenia: a review and reconceptualization.
    Davis KL; Kahn RS; Ko G; Davidson M
    Am J Psychiatry; 1991 Nov; 148(11):1474-86. PubMed ID: 1681750
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel dopamine receptors half a decade later.
    Sokoloff P; Schwartz JC
    Trends Pharmacol Sci; 1995 Aug; 16(8):270-5. PubMed ID: 7482988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of dopamine for the pathophysiology of schizophrenia.
    Meisenzahl EM; Schmitt GJ; Scheuerecker J; Möller HJ
    Int Rev Psychiatry; 2007 Aug; 19(4):337-45. PubMed ID: 17671867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The case of frontostriatal dysfunction in schizophrenia.
    Robbins TW
    Schizophr Bull; 1990; 16(3):391-402. PubMed ID: 2287930
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Neuroendocrinology and schizophrenia research].
    Müller-Spahn F
    Monogr Gesamtgeb Psychiatr Psychiatry Ser; 1991; 64():1-96. PubMed ID: 1682802
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.